BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31835157)

  • 1. Gender of offspring and risk of ovarian cancer: The HOPE study.
    Fu Z; Moysich K; Ness RB; Modugno F
    Cancer Epidemiol; 2020 Feb; 64():101646. PubMed ID: 31835157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.
    Modugno F; Fu Z; Jordan SJ; Group A; Chang-Claude J; Fortner RT; Goodman MT; Moysich KB; Schildkraut JM; Berchuck A; Bandera EV; Qin B; Sutphen R; McLaughlin JR; Menon U; Ramus SJ; Gayther SA; Gentry-Maharaj A; Karpinskyj C; Pearce CL; Wu AH; Risch HA; Webb PM
    Eur J Epidemiol; 2020 Nov; 35(11):1025-1042. PubMed ID: 32959149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breastfeeding factors and risk of epithelial ovarian cancer.
    Modugno F; Goughnour SL; Wallack D; Edwards RP; Odunsi K; Kelley JL; Moysich K; Ness RB; Brooks MM
    Gynecol Oncol; 2019 Apr; 153(1):116-122. PubMed ID: 30686553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender of offspring and maternal risk of invasive epithelial ovarian cancer.
    Baik I; Lambe M; Liu Q; Cnattingius S; Mucci LA; Riman T; Ekbom A; Adami HO; Hsieh CC
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2314-20. PubMed ID: 18006920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational weight gain and risk of epithelial ovarian cancer.
    Fu Z; Kelley JL; Odunsi K; Edwards RP; Moysich K; Modugno F
    Cancer Causes Control; 2021 May; 32(5):537-545. PubMed ID: 33616777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender of offspring and maternal ovarian cancer risk.
    Gierach GL; Modugno F; Ness RB
    Gynecol Oncol; 2006 Jun; 101(3):476-80. PubMed ID: 16364411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
    J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women.
    Riman T; Dickman PW; Nilsson S; Nordlinder H; Magnusson CM; Persson IR
    Eur J Epidemiol; 2004; 19(11):1011-9. PubMed ID: 15648594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.
    Cannioto R; LaMonte MJ; Risch HA; Hong CC; Sucheston-Campbell LE; Eng KH; Brian Szender J; Chang-Claude J; Schmalfeldt B; Klapdor R; Gower E; Minlikeeva AN; Zirpoli GR; Bandera EV; Berchuck A; Cramer D; Doherty JA; Edwards RP; Fridley BL; Goode EL; Goodman MT; Hogdall E; Hosono S; Jensen A; Jordan S; ; Kjaer SK; Matsuo K; Ness RB; Olsen CM; Olson SH; Leigh Pearce C; Pike MC; Anne Rossing M; Szamreta EA; Thompson PJ; Tseng CC; Vierkant RA; Webb PM; Wentzensen N; Wicklund KG; Winham SJ; Wu AH; Modugno F; Schildkraut JM; Terry KL; Kelemen LE; Moysich KB
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1114-24. PubMed ID: 27197285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
    Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R
    Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Am J Epidemiol; 2002 Aug; 156(4):363-73. PubMed ID: 12181107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin therapy and association with ovarian cancer risk in the New England Case Control (NEC) study.
    Akinwunmi B; Vitonis AF; Titus L; Terry KL; Cramer DW
    Int J Cancer; 2019 Mar; 144(5):991-1000. PubMed ID: 30006925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Douching, Talc Use, and Risk for Ovarian Cancer and Conditions Related to Genital Tract Inflammation.
    Gabriel IM; Vitonis AF; Welch WR; Titus L; Cramer DW
    Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1835-1844. PubMed ID: 31455671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.
    Grant DJ; Moorman PG; Akushevich L; Palmieri RT; Bentley RC; Schildkraut JM
    Cancer Causes Control; 2010 Jul; 21(7):991-8. PubMed ID: 20309725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study.
    Harris HR; Titus LJ; Cramer DW; Terry KL
    Int J Cancer; 2017 Jan; 140(2):285-291. PubMed ID: 27667654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tea, coffee, and caffeinated beverage consumption and risk of epithelial ovarian cancers.
    Leung AC; Cook LS; Swenerton K; Gilks B; Gallagher RP; Magliocco A; Steed H; Köbel M; Nation J; Brooks-Wilson A; Le ND
    Cancer Epidemiol; 2016 Dec; 45():119-125. PubMed ID: 27810483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk.
    Mills PK; Riordan DG; Cress RD; Goldsmith DF
    Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis.
    Wang KC; Chang WH; Lee WL; Huang N; Huang HY; Yen MS; Guo CY; Wang PH
    BMC Cancer; 2014 Nov; 14():831. PubMed ID: 25403543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women.
    Sköld C; Bjørge T; Ekbom A; Engeland A; Gissler M; Grotmol T; Madanat-Harjuoja L; Gulbech Ording A; Stephansson O; Trabert B; Tretli S; Troisi R; Sørensen HT; Glimelius I
    Int J Cancer; 2018 Oct; 143(8):1858-1867. PubMed ID: 29737528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.